Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy
Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy have?
Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy published?
Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy has 2024 year in the ScholarIQ index.
What is the open-access status of Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy?
Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy has closed oa status in the ScholarIQ index.
What is the DOI of Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy?
The DOI for Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy is on the source record.
What is the PMID of Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy?
The PMID for Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy is on the source record.
What is the OpenAlex record for Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy?
The OpenAlex for Engineering Modular Peptide Nanoparticles for Ferroptosis‐Enhanced Tumor Immunotherapy is on the source record.